Much remains to be discovered about Lupus. Not just disease mechanisms and new treatments, but also a better understanding of what it means to live with lupus, the day to day issues faced by patients and their relatives, the impact on social and psychological functioning, … To help people living with lupus bring their life experience to the table, LUPUS EUROPE created Patient panels, by and For people with lupus. The panels bring together 10-15 persons living with lupus from all over Europe to discuss topics of interest. the discussions are animated by People living with lupus themselves, creating a unique atmosphere in the group, and allowing to speak in full confidence, without the fear of the “white blouse”, or the impression that “there must be a correct answer”. Participants can simply be themselves and speak their voice…

3 main patient panels have taken place so far:

Patient panel I on treatment

In  November 2014, 10 Lupus affected persons from 7 countries shared their experience about “treatment”, with the view to help improve the quality of life of people living with lupus. The Panel Brought new understanding of treatment, which participants defined as “any product or activity that aims at improving the person with lupus’ quality of life” and resulted in the issuance of 3 letters addressed respectively to People living with lupus, patients organizations, and the medical community, addressing how they each can help in this area. A full report of  this panel can be found here.

Patient panel II on the burden of living with lupus

In March  2016 , a new panel aimed at further exploring the burden of living with lupus, and to dive into the burden of treatment day after day. One of its objective was to understand the journey with the disease, how the Patient Engagement model used in Health psychology applies to people living with lupus, and the consequences for Patient organisations. The model was validated and its implications for patient organisations, and how they need to address differently patients based on where they are in their journey with lupus are significant. A complete report on this patient panel can be found here.

This panel also resulted in a publication by D. Mazzoni in the magazine Muskulo-skeletal care, which you can download here .

A specific session was dedicated to Clinical trials, seeking to understand what would cause patients to join or not a Clinical trial, and too stay committed till the end.

 

Patient panel III on Youth

In May 2018, our 3rd patient panel was organised on the theme of youth. 10 Lupus affected young people, aged 18 to 26, from all over Europe shared their experience of living with lupus. The agenda was focused on the topics of interest and issues they identified themselves ahead of the Friday to Sunday gathering.  While they considered taking pills every day as a key problem, they preferred to focus on the collective issues of being understood by friends and family and having to live with limitations. A big “Wow” was the feeling of guilt expressed by several female participants (guilt of imposing limits to their partners, guilt of not being able to do as much as others, …). This guilt seems to be a very important underlying dimension of their social and affective life, which is likely much misunderstood by doctors and patient organizations. Young people with lupus remain fundamentally more positive on their life with lupus than the average patients. Their messages to other young people with lupus are reassurance, and positivism, and while they perceive lupus as being “all over their lives”, they want to make sure they are not ruled by it, and want to have no obligations relating to it… On the medical front, when we probed what would drive them to consider joining a clinical trial, clear first media is their lupus doctor, second are national lupus groups and LUPUS EUROPE. A full report of this panel can be downloaded here.

 

LUPUS EUROPE intends to continue running patient panels, so stay tuned on this page, where more information will be available as we progress 🙂

Live Facebook Feed

Comments Box SVG iconsUsed for the like, share, comment, and reaction icons

Today is rare disease day!

🚨 There are over 300 million people who live with a #RareDisease in #europe.

🌎 Today, we join our fellow patient organisations that work towards a better life for people with rare diseases and their families.

🔴 Some facts about #rarediseases:

1️⃣ There are more than 6000 identified rare diseases.

2️⃣ Rare diseases currently affect 5% of the worldwide population.
The true impact of rare diseases is much wider, however, with those affected in Europe in the millions, as the disease affects not only the patient but also our loved ones.

3️⃣ 72% of genetic diseases are genetic, although #lupus is not one of them.
👉 Lupus is not a genetic disease. Although it is very much related to genes, there are other factors that play a role in its manifestation.

4️⃣ 👶Neonatal #lupus is a rare congenital disorder that some infants of mothers with lupus and anti-Ro/SSA and/or anti-La/SSB antibodies develop.
The most serious complication of neonatal lupus is a heart condition known as congenital heart block.

5️⃣ Having an early diagnosis is key to having access to the right treatment. This has an impact on physical and mental health and, therefore, on the quality of life.

Along with organisations like Rare Disease Day and EURORDIS-Rare Diseases Europe, we will carry on working towards an early diagnosis, access to treatment and equality for #RareDisease patients 🙌.

Thank you for your support on this #rarediseaseday!

#ShareYourColours
... See MoreSee Less

Image attachment
Image attachment
Image attachment
Image attachment
Image attachment

#lupus is a #RareDisease that affects nearly 500,000 people in Europe. Furthermore, there are over 300 million people who live with a #RareDisease in #europe.

Today, along with Rare Disease Day, patient organisations around the world advocate for equity for people living with a rare disease

#ShareYourColours and help us spread the word by liking and sharing. Remember that you can also download the material of the official campaign on the website

f.mtr.cool/iyctvzvvtj
... See MoreSee Less

#Lupus is a #RareDis

Today is #RareDiseaseDay!

And we have joined Rare Disease Day campaign.

Everyone deserves equal opportunities, access to healthcare ➕ early diagnosis, which is key to setting a treatment plan &, hence, achieving a good quality of life.
#ShareYourColours

www.youtube.com/watch?v=7J1oTfoIOGw
... See MoreSee Less

Today is #RareDiseas

😃 Throwback to the HMA/EMA Multi-Stakeholder Workshop on Artificial Intelligence.

Watching Alain Cornet show the world what #LupusGPT really is still gives us goosebumps! 🙌

For those who still don't know this artificial intelligence tool:

💡 LupusGPT is built by patients and doctors.
🗣️ It speaks virtually any language.
💸 It’s free and anonymous- you don’t need to create an account.
📚 It is trained exclusively on a curated repository of validated documents.
🚫 It does not invent answers.

If something is not in the repository, LupusGPT will clearly say so. It will not guess. It will not generate false information.

🥹 Seeing LupusGPT presented at such a high-level regulatory forum confirmed something important:
Patient-led innovation can meaningfully contribute to the future of AI in medicine when it is built responsibly.

🔗 Try it here! lupusgpt.org/

🧠 Are medical terms confusing? Prefer shorter explanations in simple language?
Try #EasyLupus! The easy-read version of LupusGPT: easy.lupusgpt.org/
... See MoreSee Less